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SUMMARY
Accurate tumor tracking remains as a major challenge in radiation therapy.
Large margins are added to the clinical target volume (CTV) to ensure the treatment
of tumor in presence of patient setup uncertainty and that caused by intra-fractional
motion. Fiducial seeds and calypso markers are commonly implanted into the dis-
ease sites to further reduce the dose delivery error due to tumor motion. For more
accurate dose delivery and improved patient comfort, the use of radioactive tracers
in positron emission tomography (PET) as non-invasive tumor markers has been pro-
posed - a concept called emission guided radiation therapy (EGRT). Instead of using
images obtained from a stand-alone PET scanner for treatment guidance, we mount
a positron imaging system on a radiation therapy machine. Such an EGRT system
is able to track the tumor in real time based on the lines of response (LOR) of the
tumor positron events, and perform radiation therapy simultaneously. In this work,
we propose a typical treatment scheme for EGRT and validate the EGRT concept
using computer simulations. EGRT can be implemented in any modality where tu-
mor tracking is needed, such as Intensity-Modulated Radiation Therapy (IMRT) and
tomotherapy. EGRT’s advantage on increased dose delivery accuracy is demonstrated
using a pancreas tumor case and a lung tumor case without the setup margin and
motion margin for IMRT treatment and using a prostate tumor case without setup
margin for tomotherapy treatment. The emission process is simulated by Geant4
Application for Tomographic Emission package and Linac dose delivery is simulated
using a voxel-based Monte Carlo algorithm. The tumor tracking error can be con-
trolled within about 3 mm which indicates margins can be significantly reduced. The
dose distributions show that the proposed EGRT can accurately deliver the prescribed
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dose to the CTV with much smaller margins. Although still in a preliminary research
stage, EGRT has the potential to substantially reduce tumor location uncertainties




1.1 Overview of radiation therapy
Radiation is intensively involved in the two most important research topics in med-
ical physics, which are medical imaging and radiation therapy. In medical imaging,
radiation is used for cancer diagnosis; while in radiation therapy, radiation is used
to control and destroy malignant cells in order to perform cancer treatment. Al-
though imaging and therapy are quoted as two separate research sub-fields, imaging
is actually involved in every key step of therapy such as computed tomography (CT)
simulation, treatment planning and radiation delivery.
Since radiation therapy was first used, its development is tightly connected with
the evolution of imaging techniques[23]. In other words, radiation therapy is es-
sentially imaging-orientated and imaging-guided. In early days when x-ray was first
discovered, radiologists located the tumor by making use of 2-dimensional (2D) trans-
mission images of human body. Later on due to the emergence of CT, the tumor is
targeted with highly conformal dose distribution with the help of 3-dimensional (3D)
reconstructed CT images. This huge improvement from 2D to 3D resulted in sig-
nificant dose reduction to normal tissues and more uniform dose distribution inside
the tumor volume, which dramatically increase the tumor control probability. Recent
technical advances brought up the intensity-modulated radiation therapy (IMRT)
which has further enhanced this improvement[5][6].
However in practice, unpredictable uncertainties exist in multiple processes such
as tumor volume delineation or target localization due to reasons such as intra- and
inter-organ motion. Without reducing these uncertainties, IMRT technique will not
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be able to fully exhibit its advantages on cancer treatment. Therefore, intensive
research activities recently focus on image-guided radiation therapy (IGRT) to elim-
inate such uncertainties, especially that in tumor tracking in order to strengthen the
power of IMRT techniques. Here IGRT mainly refers to the new technologies em-
ployed in the processes of radiation planning, patient setup and in the procedures of
delivery, in which cutting-edge image-based tumor definition methods, patient posi-
tioning devices, motion management tools and radiation delivery guiding tools are
used[23]. The ultimate goal of IGRT is to locate the tumor with high accuracy and
to verify this accuracy in the radiation delivery process in order to ensure the tumor
is treated as planned.
Clinically, two types of therapy scheme are typically available: external beam
therapy and tomotherapy. Different from external beam therapy, in tomotherapy,
radiation is delivered slice by slice with image guidance. Therefore, IGRT can be and
is actually applied in both therapy schemes.
1.2 Treatment margins
A radiation treatment margin is routinely used in radiation therapy and is very im-
portant for clinical radiotherapy[4]. It mainly refers to the area of healthy tissue
around the target area that also receives radiation. The radiation treatment margin
may be the tissue around an existing tumor, or around a lumpectomy cavity. Part of
the goal of the radiation therapy is to find out ways to reduce treatment margins as
much as possible, so that less healthy tissue is affected by radiation.
The concept of gross tumor volume (GTV), clinical target volume (CTV) and
planning target volume (PTV) is essential to understand the margin concept. GTV
is the gross demonstrable extent and location of the tumor, which may consist of
primary tumor, metastatic lymphadenopathy, and other metastasis. The GTV is
usually based on information obtained from a combination of imaging modalities (CT,
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MRI, ultrasound, etc.), diagnostic modalities (pathology and histological reports,
etc.) and clinical examination. CTV consists of demonstrated tumor(s) if present
and any other tissue with presumed tumor, representing true extent and location
of tumor. This volume has to be treated adequately in order to achieve the aim of
therapy, cure or palliation. PTV consists of CTV plus an internal margin (margin for
internal physiological movements) plus an additional margin for patient movement
and set-up uncertainty. Margin has to be large enough to compensate for both internal
movements and set-up uncertainty. The illustration of these tumor volumes and
margins is shown in Figure 1.
Figure 1: Illustration of Tumor volumes including GTV, CTV and PTV that lead
to margin concept. OAR is organ at risk and ITV refers to internal target volume.
Usually margins depend on organ motion which causes internal margins, and
patient set-up and beam alignment which brings external margins. The internal
margin is designed to take into account the variations in the size and position of the
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CTV relative to the patient’s reference frame (usually defined by the bony anatomy),
i.e., variations due to organ motions such as breathing, bladder or rectal contents, etc.
The external margins are mainly caused by setup uncertainties, machine tolerances
and intra-treatment variations. Margins can be non-uniform but should be three
dimensional. A thumb of rule of determining magnitude of margins is that the target
is in the treated field at least 95% of the time. In this work, the internal margins
are mainly represented by motion margins (margins caused by motion) while the
external margins are mainly represented by setup margin (margins caused by setup
error). One goal of this study is to reduce margins so as to achieve treatment with
few or even no margins, including motion margins and setup margins by our proposed
accurate tumor tracking method.
1.3 Difficulties of current radiation therapy practice
In current radiation therapy practice, IGRT is widely used clinically. As for dose
delivery tool, Varian’s medical system has broad applications. For example, Varian
Triology Linac, Varian HDR Brachytherapy system and so on. One typical IGRT
process based on Varian’s Linac system is shown in Figure 2.
Figure 2: A typical IGRT process including mainly three steps.
One such typical IGRT process starts from CT simulation where patient anatomy
CT images are acquired. Based on the fusion images of MRI and CT images, the
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treatment plan can be generated to treat the tumor in the planned position. The
planned position is defined as the tumor position in the CT/MRI fusion images con-
toured by the responsible physicians or residents. Thereafter, the patient is setup
by the radiotherapist with the help of various immobilization tools such as thermal
masks and wing board, whose purpose is to ensure that the patient is set up in the
planed position. The on board imager (OBI) is used further to adjust the patient
position with the help of bone anatomy landmarks and verify that the tumor is in
the planned position, manually by radiotherapist. However, this method adjusts the
position in an indirect way, which decreases its effectiveness.
For the process stated above, although IGRT may significantly improve the ra-
diation therapy performance, it still currently encounters remarkable difficulties in
locating the tumor precisely, especially for the tumor in motion. One of the biggest
difficulties comes from the fact that the tumor locating method is an indirect one
which makes it essentially imprecise. For example, the immobilization devices fix the
patient to ensure that the patient is always in the same position for every fractionated
treatment. However, setup error still exists in spite of those immobilization devices
which means even if the fixed position can be made always the same for every treat-
ment it may not be exactly the same as planned. Another example is the OBI. OBI
is used as image guidance to further verify the patient is in the appropriate position.
However, OBI aligns the patient according to the bony anatomy structures rather
than the real tumor tissues. This will inevitably bring errors, especially those from
therapist operations.
Another essential difficulty comes from the motion which includes the organ mo-
tion, tumor motion, and patient motion. Current radiation therapy practice could
not actually deal with the small irregular motion caused by organ motion and patient
motion which may exist in a significant amount of cancer types. For large periodic
motion like respiratory movement, although gating technique has been proposed[16],
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this method is not accurate because the respiratory motion only has a rough pat-
tern and cannot be accurately determined using gating technique itself. Besides, this
method assumes that the tumor motion is consistent or has the same pattern with
the marker motion, which is very likely not the case and still in debate. Therefore,
fiducial markers or Calypso are commonly used[3][10]. However, they are invasive,
which causes significant patient discomfort, and thus cannot achieve a satisfactory
performance.
Due to all the issues discussed above, IGRT still cannot achieve its ultimate goal
of locating the tumor with sufficiently high accuracy in an optimal way. Therefore,
large margins, typical in magnitude of several centimeters, are added to CTV and
even more for GTV[13][20]. To further improve the tumor tracking accuracy and
reduce the tumor margins, other solutions are needed. The new solution needs to
either address those difficulties of IGRT or bring new techniques that are free of
those disadvantages.
1.4 Other approaches and emission guidance as a viable
choice
Setup error can be viewed as one-time motion. Therefore, the dilemma of current
IGRT practice is essentially motion problem. Several attempts to solve tumor motion
problem have already been discussed briefly in previous sections. Here this topic is
examined further in the following. These attempts are either actually commercially
available or under development, which include X-ray guided therapy[12], respiratory
gating[14], implantable beacons and MRI guided therapy[18]. However, X-ray imag-
ing is not a good choice since it only has poor soft-tissue contrast. Most existing
systems rely on tracking fiducial markers or bony anatomy to determine or predict
tumor location. Respiratory gating is ineffective and inaccurate, since it assumes the
motion of the marker is consistent with the lung motion, which is still in debate. In
addition, the human breathing cycle is variable in nature. Fiducials or beacons are
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not suitable for all patients with lung tumor since the use of them may introduce lung
collapse[1]. Moreover, implantable markers can also drift during treatment. Low-field
MRI generally is not able to generate good quality volumetric images[17], while high-
field MRI will introduce dose hot-spots outside of the target volume because of the
electron return effect.
In search of an alternative method for real-time tumor tracking which is the main
dilemma of current IMRT and IGRT practice, emission guidance becomes a viable ap-
proach. Emission guidance refers to the guidance provided by any radioactive tracer
emission originating from the tumor site. In this work, positron emission is mainly
studied. Positron emission (PE) is mainly studied since line of response (LOR) of
PE naturally defines the projection line to localize the tumor. Currently the most
common application of positron emission is Positron Emission Tomography (PET).
PET is emerging as the imaging standard in cancer diagnosis, offering higher sensi-
tivity and specificity compared to all other imaging modalities across the majority of
cancer types[19]. With the use of a radio-labeled tracer such as 18F − FDG, PET
depicts metabolic activity, and makes tumors to light up. Other PET tracers such
as F-MISO and FLT can show other characteristics of tumors such as hypoxia and
proliferation. Despite these distinct advantages, PET has not been incorporated into
real-time adaptive radiation therapy since it takes minutes to generate a full image.
That is, PET or PE is not currently used during treatment. However, we may not
need a full PET image to locate the tumor, so it is possible to include PET or rather
positron emission into real-time adaptive radiation therapy. This is where we start
to propose a new approach and its corresponding system to guide radiation therapy.
1.5 Our proposed approach
In order to address the issues of IGRT and based on the discussion in last section,
we propose a novel and practicable approach to directly guide radiation therapy, a
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concept called Emission Guided Radiation Therapy (EGRT). The work presented
in this thesis will mainly introduce the concept, the EGRT system design and then
validate the concept through simulation study for two therapy schemes which are
IMRT therapy scheme and tomotherapy therapy scheme.
The EGRT concept is straightforward. Emission guidance refers mainly to the
guidance provided by the emission events of the radioactive tracers, for example 18F−
FDG, which is injected into patient before radiation delivery. After injection, the
radioactive tracers will concentrate in the tumor due to highly active metabolism and
thus positron emission will occur mainly in the disease sites, highlighting the tumor
site. When emission guidance is incorporated into simultaneous radiation delivery,
tumor lights up and can be located directly in almost real time which will solve the
dilemma of IGRT discussed before. For hardware to achieve this, we mount PET
detectors onto a typical Linac system, arranged symmetrically around the isocenter
of the system gantry.
The advantages of EGRT are obvious and various. First of all, EGRT is noninva-
sive because the radioactive tracers are noninvasive and can be injected into patient
easily based on current nuclear medicine technique. Also, in EGRT, the functional
information is presented which is good for therapy purpose. Moreover, EGRT is a
direct method of locating tumor in almost real time, quite different from the indirect
tumor tracking method such as IGRT. Besides, through our simulation, EGRT shows
high accuracy of tumor tracking. In this case, very small margins or even no margins
are needed due to the fact the tumor can be located almost in real time and there is
no need to use large margins to compensate for those certainties discussed. This is





Simulation is a good way to validate the proposed EGRT concept since the concept
can be tested easily and effectively without building a real system. However, practical
simulations should be carried out to make the simulations convincing. Thus, effective
simulation tools are needed. As for the validation of EGRT concept, two sets of sim-
ulation tools are needed. One is needed to simulate the process of tumor localization,
i.e. whether the tumor can be located in almost real time and how accurate it would
be, and the other one is needed to simulate the process of dose delivery according to
the dynamically determined tumor position. In the tumor localization part, Geant4
Application for Tomographic Emission (GATE) package, a GEANT4 based dedicated
Monte Carlo simulation tool for positron emission, is used to simulate the process of
positron emission after the radioactive tracers are injected into the patient. The data
output of GATE is then used to determine the position of the tumor; while in the
dose delivery part, voxel base Monte Carlo package VMC++ and optimization pack-
age MOSEK is used to determine the dose kernel for making treatment plan and
computing dose distribution and beamlet intensity. For both parts, realistic human
phantom is needed to do such evaluation and XCAT phantom is applied for this pur-
pose. Besides the simulation tools, the treatment planning will also be discussed in
this chapter because it is a common method for both therapy schemes which will be




MOSEK is an optimization package for making treatment plan in this work. The
MOSEK optimization package can be used to solve large-scale mathematical opti-
mization problems[2]. MOSEK provides fast and efficient specialized solvers for a
lot of types of optimization problems including linear problems, quadratic problems,
general convex problems and mixed integer problems. This package can be used with
various interfaces including C/C++, .NET, Java and Python. In this work, MOSEK
MATLAB optimization tool box is called to run MOSEK optimization codes. The
optimization problem of treatment planning is illustrated in the treatment planning
section.
2.2.2 GATE
GATE, short for Geant4 Application for Tomographic Emission, is a PET/SPECT
dedicated simulation platform based on Geant4, an opensource package developed
by the international OpenGATE collaboration[21]. GATE can be run on multiple
operating system platforms including Window and Linux. In this work, GATE is run
in Ubuntu 8.10. GATE is dedicated to the numerical simulations in medical imaging,
especially for simulations of Emission Tomography (Positron Emission Tomography -
PET and Single Photon Emission Computed Tomography - SPECT). Due to the fact
that GATE coding can be done using an easy-to-learn macro mechanism and highly
sophisticated experimental settings can be easily configured, GATE now plays a key
role in the design of new medical imaging devices, in the optimization of acquisition
protocols and in the development and assessment of image reconstruction algorithms
and correction techniques[21].
In order to understand how GATE works, a summary of steps to write a GATE
script is given below:
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1. Define the scanner geometry
2. Define the phantom geometry
3. Set up the physics process
4. Initialize the simulation
5. Set up the detector model (digitizer)
6. Define the sources
7. Specify the data output format
8. Start the data acquisition
GATE is not only able to construct user-defined phantom, but also able to read in
voxelized phantom. A picture of GATE simulation is shown in Figure 3.
One of the data outputs of the GATE simulation is the coincidence counts infor-
mation which records where the coincidence events are detected. In this work, this is
the main data output to be used.
2.2.3 VMC++
VMC++ is a highly efficient Monte Carlo dose calculation engine for radiation ther-
apy treatment planning[9][8]. It has been validated against well established codes.
VMC++ can be easily installed and run under any PC that uses a DOS shell. The
main command of running VMC++ is shown below:
vmc.exe input_file
Therefore, in order to run the VMC++ for the wanted simulation, the main task
is to write an input file which includes the following information:
• The geometry of the simulated phantom
11
Figure 3: Illustration of GATE simulation system. The whole system is defined in
a cubic volume called world. Calculation is done only for particles in world volume.
The ring detector system is placed around the isocenter of the world volume. The
voxelized phantom can be read in to be put in the isocenter of the volume.
12
Figure 4: Illustration of VMC++ geometry(1). Here defines the geometry of one
simulation example. Sources are placed in different positions. The cross section of
radiation is defined by beamlets.
• Defined source position and beamlet edges coordinates
• Source spectrum
• Defined Monte Carlo simulation parameters
One input file only includes one point source and one beamlet. The beamlet is
usually placed in the midpoint between the point source and geometry isocenter.
Therefore, one simulation will need hundreds or even thousands of input files, de-
pending on how many beams are needed. For each input file, it will generate a line
of radiation and the beamlet edges coordinates need to be defined to give the cross
section of this line of radiation because only the dose from the radiation that goes
through the beamlet will be calculated. Thus the cross section of this line of radiation
can be tuned by changing the beamlet edges parameters. One illustration of VMC++
is shown in Figure 4 which defines the geometry of one simulation example and in
Figure 5 which gives the corresponding dose output.
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Figure 5: Illustration of VMC++ geometry(2). Here shows the dose output images
of the phantom after the radiation is delivered.
Based on the characteristics of VMC++, it is used in this work as the simulation
tool for getting the dose distribution of the radiation delivered by a typical Linac in
the phantom. Each output for each input file of the VMC++ is a 3D dose distribution
for the specified point source defined in the input file that penetrates the phantom,
also called the dose kernel.
2.3 Treatment planning
For treatment plan, inverse treatment planning technique is typically used in current
radiation therapy. It is usually used to optimize the treatment beam apertures and
weights such that the delivered dose on the patient is as close as possible to the
prescribed dose[24]. The delivered dose distribution on the patient, d, has a linear
relationship with the intensity of the beamlets, x
d = Ax
where d is the vectorized 3D dose distribution and the beamlet intensity x is a 1D
vector that consists of rowwise concatenations of beamlet intensities for all fields[24].
Each column of matrix A is a beamlet kernel, corresponding to the dose distribution
achieved by one beamlet with unit intensity for all the considered voxels.
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Typically the sum of the square errors of the delivered dose relative to the pre-
scribed dose is used as the optimization objective function. Therefore, the treatment






where the index i denotes different structures; λi is the relative importance factor[15][22];
each column of matrix Ai is the beamlet kernel corresponding to the ith structure,
and di is the prescribed dose for the ith structure. The same form of objective func-
tions for both the target and the critical structures is used, however, a low prescribed
dose is used for the critical structures. Through the use of optimization package, all





EGRT is a concept of guidance in radiation therapy. Therefore, EGRT can be applied
in different modalities where tumor tracking is needed, e.g. IMRT and tomotherapy.
In IMRT treatment, the position will first be determined to reduce the setup uncer-
tainties and then monitored in almost real time to aid the radiation delivery process.
In tomotherapy treatment, the situation is slightly different. The tumor position
is gradually determined with an adaptive dose delivery scheme. In this work, both
IMRT scheme and tomotherapy scheme are investigated. This chapter will discuss
the case of IMRT scheme.
In both treatment schemes, we have used the concept of sinogram. The sinogram
concept in this work is similar to that in CT reconstruction. There are two parameters
associated with this concept, which is the angle of the LOR relative to the isocenter of
the whole system, and the displacement of LOR relative to the isocenter respectively.
The intensity of the sinogram is the number of counts or LORs that have the same
angle and displacement. In current simulation the two parameters are sampled and
thus discrete. The sample period is optimized according to phantom voxel size and
reconstruction resolution.
There are two key issues needed to be addressed in EGRT concept. One is tumor
tracking, question may include how to locate the tumor in real time and what is the
locating accuracy; the other is treatment plan modification algorithm, question may
include how to effectively modify treatment plan based on tumor position and does
the modified plan work for treatment. These two issues are important in both IMRT
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scheme and tomotherapy scheme. The main content in this chapter will focus on how
to address those questions for IMRT scheme and the main content in next chapter
will focus on how to answer those questions for tomotherapy scheme.
3.2 Proposed EGRT IMRT system design
In EGRT IMRT scheme, Linac delivers the dose in a similar way as it does in current
radiation therapy practice by using the tumor location information obtained by the
PET detectors. A schematic diagram of EGRT system for IMRT scheme is shown
in Figure 6. Such a system is able to determine the tumor location by using PET
(a) Tumor tracking (b) Dose delivery
Figure 6: The schematic diagram of the proposed EGRT system for IMRT scheme.
Left: the tumor tracking using radioactive tracers; Right: Dose delivery with the help
of detected tumor motion position for one particular field.
detectors and also to deliver the dose instantly through a treatment plan modification
process based on the tumor location information. In this case, positron imaging is
integrated into treatment used as guidance.
3.3 PET detector arrangement
The purpose and feature of EGRT system is to deliver the radiation while tracking
the tumor in real time and then improve the treatment performance based on the
dynamically acquired tumor location. Therefore, the EGRT system is designed to be
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a hybrid system, consisting mainly of a Linac accelerator and PET detectors. They
are arranged such that the tumor position could be detected, monitored and used
to aid the process of dose delivery simultaneously. Unlike as used in PET imaging
where detection is the main purpose, PET detectors cannot occupy the whole ring
because of the existence of the Linac and possible OBI devices. Thus, it is very
important to find out whether the tumor can be located in such EGRT system where
only limited PET detector coverage is available and further how much PET coverage
is needed to get a reasonable locating accuracy. In order to take this realistic situation
and consideration into account, two schemes of PET detector arrangements, which
is system with OBI arrangement and system without OBI arrangement, have been
investigated, shown in Figure 7(a) and (b).
For arrangement (a), four pieces of PET detectors are centered around the isocen-
ter and the angle θ1 is defined as the angle coverage of a single PET detector and
is symmetrical about the 45◦ axis, while in arrangement (b), two pieces of PET de-
tectors are also centered around the isocenter however the angle θ2 is defined as the
angle coverage of one PET detector and is symmetrical about the x axis.
(a) system with OBI arrangement (b) system without OBI arrangement
Figure 7: The proposed EGRT system design of two investigated PET detectors
arrangements. The EGRT system is a hybrid system, consisting of a Linac and PET
detectors. Left: shows the PET detectors arrangements with OBI devices, Right:
shows the PET detectors arrangements without OBI devices.
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Obviously, for arrangement (a), the total detector coverage is equal to 4θ1 while for
arrangement (b), the total detector coverage is equal to 2θ1. For the same detector
coverage, it is expected that the system with OBI arrangement be able to detect
the tumor position more accurately because the collected data is more uniformly
distributed in all directions.
Several issues and challenges need to be handled for such an EGRT system. One
of them is to localize the tumor using incomplete LORs data since some LORs es-
cape because of the partial detector coverage. A second challenge comes from the
background signals when background tissue has an uptake ratio that is close to or
even higher than that of the tumor. The reasonable uptake ratio should be deter-
mined that achieves acceptable EGRT performance. Another challenge is how fast
the EGRT system may track the tumor location. Without a good time resolution,
EGRT system may not exhibit its power on tumor tracking, especially for lung tumor
motion.
3.4 Tumor localization
The tumor localization method described in this work is one way to make use of
emission guidance for IMRT treatments, designed to be efficient and practical. The
purpose of the tumor localization is to determine the real-time tumor location and
further use it to achieve a satisfied treatment with acceptable dosimetry performance.
Once the tumor position is determined to be different as the planned one, treatment
plan needs to be modified instantly to take this position shift into account in order to
still achieve the planned dose distribution. After the radioactive tracer injection, GTV
will start to emit positrons and thus LORs can be determined based on the coincidence
events. These LORs data are first reorganized into sinogram and the sinogram is
then used to reconstruct the patient tumor image with background present. In the
reconstructed images, since the tumor usually has higher uptake of radioactive tracer,
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Figure 8: Illustration of localization method in 2D case.
it will have higher reconstructed image values. Based on this difference between the
tumor and background, the tumor contour, obtained from the CT simulation, can be
then applied onto the reconstructed tumor images to find out tumor location which
is determined to be the position that maximizes the sum of image values that fall
into the tumor contour, assuming the tumor does not deform. Figure 8 gives an
illustration of our localization method in 2 dimensional (2D) case.
The potential tumor region is represented by f(x, y) and the tumor contour by
g(x, y). Since we assume the tumor does not deform, the position of the tumor can
be represented by one single point. Suppose initially the tumor contour is placed at
origin of the reconstructed image space. The tumor contour is then moved into the
potential tumor region by a vector (x0, y0). (x0, y0) represents any point in potential
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tumor region so that the tumor contour can be moved around the whole region by
varying (x0, y0). Based on the principle discussed above, the tumor position (x∗, y∗)
is determined to be the point (x0, y0) that maximizes∑
f(P )g(P )
for any point in tumor contour, where g(x, y) represents the tumor contour and is
equal to 1, f(x, y) represents the reconstructed image values of the potential tumor
region, P is any point in tumor contour. The computation of this process depends
on the step size of tumor’s moving around at both x and y directions, i.e. the
interpolation intensiveness of the algorithm.
The localization accuracy can be affected by factors such as the number of events
used to reconstruct the tumor images, the temporal resolution, locating algorithm ef-
fectiveness, data completeness and uptake ratio. Noise may degrade the reconstructed
image quality and thus affect the locating accuracy. High temporal resolution may
decrease the number of events for each phase and increase data noise. Interpola-
tion intensiveness of the locating algorithm will have a significant influence on the
accuracy. The incomplete LORs data will cause artifacts on reconstructed images
and degrade localization accuracy. Low uptake ratio of tumor will make tumor more
difficult to be identified. Therefore, in order to achieve the optimized localization
accuracy, these factors need to be examined carefully.
3.5 Treatment plan modification
Typically the treatment plan keeps unchanged during the treatment since the tumor
position change is taken into account by adding margins or using gating technique.
However in EGRT, no margin is used and thus the treatment plan needs to be modified
instantly as the tumor moves, allowing no time to be made anew and still achieving
the planned tumor dose distribution with negligible errors.
The proposed treatment modification algorithm works as follows. The main idea
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Figure 9: 2D illustration of treatment plan modification method.
is to shift the fluence map of each field to capture the tumor all the time. Figure 9
gives a straight illustration of this idea.
Suppose one IMRT treatment has N treatment fields, noted as βi, i = 1, 2, 3, ...N .
The tumor position change is noted as (∆x,∆y,∆z). For all N fields, the fluence map
is shifted in the plane of 2D beam eye’s view (BEV) of each field with a magnitude
calculated by the following formula:
l = ∆xcos(βi) + ∆ysin(βi), i = 1, 2, 3, ...N
a = ∆z, i = 1, 2, 3, ...N
where l indicates the shift in lateral direction and a indicates the shift in axial
direction. This shift can be done using a 2D cubic interpolation. After modification,
the fluence map is ready to be used to deliver the dose to the tumor in shifted position.
The dose kernel may be slightly different due to the position change, causing error;
however, the error caused by this fact is small enough to be neglected in terms of
dose distribution since the magnitude of this position change is relatively small. In
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the case of significant motion, such as lung tumor motion, where kernel change due
to location change may possibly cause large errors, gating technique can be used so
that treatment plan does not need to be changed at all.
3.6 Treatment scheme in IMRT
EGRT can be implemented in any radiation therapy modality wherever tumor track-
ing is involved, such as IMRT and tomotherapy. In this work, the IMRT treatment is
mainly investigated and the tomotherapy treatment will be briefly discussed. Based
on the proposed tumor localization and treatment modification algorithms, the treat-
ment scheme of EGRT is summarized to be shown in Figure 10. The treatment
scheme is mainly composed of two parts, which are tumor localization and dose de-
livery. The delivery part relies on the localization part to provide the tumor position
change information for modifying the treatment plan. In dose delivery part, based on
the information of CTV, rather than PTV since margin is no longer needed in EGRT
to account for the tumor uncertainties, a typical IMRT treatment plan could be made
to treat the tumor. However, this treatment plan is made only for the planned tumor
position. Once the tumor position shifts, it cannot be directly applied for delivery.
So right before dose delivery, the tumor localization part will be called to determine
the location change. With the location shift determined from the planned position,
the planning will be modified accordingly using the proposed treatment modification
algorithm. Depending on how fast the motion is, different sliding time windows can
be used to update the tumor location. For tumors such as lung tumor which shows
fast motion, relatively small time window such as sub-second time window can be
used in order to monitor the tumor motion in almost real time. With both parts, a
clinically acceptable IMRT treatment that is planned for CTV can be achieved with
few or even no margins added.
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Figure 10: A summary of EGRT treatment scheme. The treatment scheme is com-
posed of two parts: tumor localization and dose delivery. The updated tumor loca-
tion obtained by reconstruction and localization algorithms will be used to modify
the treatment plan to finally achieve a successful treatment.
With the proposed system design and corresponding treatment scheme, two es-
sential questions need to be answered in order to validate the EGRT concept. One is
to determine whether the EGRT system can achieve sufficiently high locating accu-
racy; the other is to verify whether using our proposed treatment plan modification
algorithm, the treatment performance, i.e. the planned conformal dose distribution,
can be maintained or improved.
3.7 Evaluation
3.7.1 Overview
In order to validate the EGRT concept and its treatment scheme, we develop the
following method to evaluate the EGRT performance, shown in Figure 11.
As shown, our proposed method of evaluation is also accordingly divided into two
parts, based on the EGRT treatment scheme, which both start from XCAT Phantom.
The XCAT Phantom provides a set of two phantoms with the same parameters and
anatomy at the same time, which is an attenuation phantom and an activity phantom.
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Figure 11: A chart flow of method evaluation. The method evaluation is also divided
into two parts similarly and used to simulate the whole process of treatment scheme
of EGRT.
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These two phantoms have different simulation purpose in the EGRT concept. The
activity phantom will simulate how the radioactive tracers will be distributed among
the patient and thus is used to locate tumor through the GATE simulation. The
attenuation phantom will simulate how the Linac will deposit dose in the patient and
what the dose distribution will be for the tumor and normal tissue. The voxel size of
the activity phantom is much smaller than the attenuation phantom and is set to be
0.98 mm by 0.98 mm by 2.5 mm. With a smaller voxel size, the tumor can be located
with a higher accuracy.
The activity phantom is to be read in by GATE, a GEANT4 based dedicated
Monte Carlo simulation tool for positron emission. The GATE output LORs Data,
which is used to determine the tumor location. The tumor can be both static and
fast moving. XCAT Phantom also generates an attenuation phantom which is to be
read in by VMC, a voxel-based montel carlo simulation package. VMC will output
the dose kernel to be read in by MOSEK, which is an optimization package. This
package is mainly used to generate the treatment plan for the simulated phantom.
With both the treatment plan and tumor location, we are able to evaluate EGRT
performance. To save computation in the MC simulation of the dose distribution, the
voxel size of the XCAT attenuation phantom is set to be 3.92 mm by 3.92 mm by 2.5
mm.
3.7.2 Reconstruction and localization
For reconstruction in this work, we use a universal 3D parallel beam reconstruction
algorithm. The reconstruction resolution is determined and optimized based on the
detector size and phantom voxel size. In this work, the reconstruction resolution is
0.98mm by 0.98mm by 2.5mm. The step of interpolation of localization algorithm
used in this work is 0.1 voxel in each direction.
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3.7.3 Two simulation cases
In order to evaluate EGRT performance and validate EGRT concept, two simulation
cases, pancreas tumor case and lung tumor case, have been investigated. The purpose
of simulating pancreas tumor case is three fold. One is to investigate whether the
tumor can be located using partial detector coverage and how the detector coverage
will influence the locating accuracy. To do this, various angles are investigated based
on the proposed algorithms. One is to find out whether high background signal will
affect the tumor locating accuracy. Another is to validate that the setup error can
be detected using the proposed PET detector arrangements so that the setup margin
can be significantly reduced. For lung tumor case, the purpose is mainly to find out
what temporal resolution can be achieved in detecting moving tumor, addressing the
challenge of fast motion detection ability, to ensure that the periodic motion actually
can be detected in almost real time in EGRT so that the motion margin can also be
remarkably reduced. To do this, a lot of simulations are needed to be carried out to
find out the best temporal resolution when tumor size, activity level and uptake ratio
are given.
Due to various reasons, IMRT is a good choice for treating pancreas tumor be-
cause of highly conformal dose distribution. Two of many difficulties for treating
pancreatic cancer are the setup error and motion indirectly caused by respiratory
motion, for which large margins have to be added to compensate. Large margins
can be decomposed into two parts, which are setup margin to compensate for the
setup error, and motion margin to compensate for the motion issue. However, in
this work, the pancreas case is used to mainly to validate that setup margin can be
reduced using EGRT with an assumption that tumor motion can be neglected. The
motion issue will be discussed and resolved in lung tumor case in which motion issue
is the main source for margins.
Figure 12 shows the one set of two phantoms generated for simulation and the
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Figure 12: The XCAT phantom images of pancreas tumor case and its reconstructed
tumor images.
self-made tumor which only is shown in activity phantom. This self-made tumor has
the same uptake ratio as other organs such as left kidney, right kidney and liver. The
left kidney, right kidney, spinal cord and small bowel are taken as critical structures
for IMRT planning according to routine clinical practice.
For the pancreas tumor, 10 fields were used at angles of 270◦, 300◦, 330◦, 0◦,
25◦, 55◦, 85◦, 115◦, 145◦, 175◦ based on a standard clinical protocol[11]. Each field
targeted the center of PTV, and contained 21 by 17 beamlets, with a beamlet size
of 5 mm by 5 mm at the source-to-axis distance (SAD). Uptake ratio of tumor over
general background is set to be 8:1. A set up error of 1.176cm in lateral direction and
1.176cm in superior direction is simulated.
Currently in IMRT clinical practice, the biggest problem associated with the lung
cancer is the respiratory motion. EGRT is a good choice for tumor motion issue.
And the main purpose of simulating the lung tumor case is to prove that the motion
margin can be reduced because EGRT can track the tumor almost in real time, even
with partial PET detector coverage. Figure 13 shows the one set of two phantoms
generated for simulation and the self-made tumor which is shown in both attenuation
and activity phantom. This self-made tumor has a 15:1 uptake ratio over surrounding
tissues. The left lung, right lung, spinal cord and heart are taken as critical structures
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Figure 13: The XCAT phantom images of lung tumor case and its reconstructed
tumor images.
for IMRT planning according to routine clinical practice.
For the lung tumor case, five fields were used at angles of 70◦, 115◦, 195◦, 230◦,
270◦ based on a standard clinical protocol[7]. Each field targeted the center of PTV,
and contained 21 by 17 beamlets, with a beamlet size of 5 mm by 5 mm at the SAD.
Uptake ratio of tumor over general background is set to be 15:1. Since it is generally
accepted that the respiratory motion is a periodic motion, we simulate a half-sino-
wave motion in the posterior-anterior direction, with a magnitude of 1.96 cm. The
respiratory cycle is set to be 5 seconds divided into 15 phases, resulting in a temporal
resolution of 0.33 s.
3.8 Results
3.8.1 Pancreas tumor case
As shown in Figure 12 (c), with full detector coverage, the tumor can be easily identi-
fied in reconstructed images. With our proposed algorithm, it is found out that for full
coverage, the position locating accuracy is about 0.8 mm. However, like mentioned
before, there is no full PET detector coverage so that it is very important to find out
how the locating accuracy change with decreasing coverage. The reconstructed im-
ages for three selected angles which are 240◦, 180◦ and 120◦ for two different detector
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Figure 14: The reconstructed images of pancreas tumor case with specific angle
coverage of 240◦, 180◦ and 120◦.
arrangements are shown in Figure 14. The result of locating accuracy for different
detector coverages is shown in Figure 15.
As expected, system with OBI arrangement has better locating accuracy for the
same angle coverage. It is found out that with approximate 150 degree, EGRT should
be able locate the tumor with an accuracy of about 1.2 mm, which is sufficiently
accurate according to clinical criteria.
As shown in Figure 16, if there is setup error, the planned dose distribution will
miss the CTV and lead to unacceptable dose distribution. That is why typically a
setup margin needed to be added to CTV. Note that the prescribed dose is normalized
to be 10−3. The same thing applies to other DVH figures.
However, as shown in Figure 17, with EGRT, before radiation delivery, the setup
error will be detected and thus the treatment plan can be modified accordingly so
that the radiation will hit the tumor as the tumor is in the planned position and thus
generate a satisfied dose distribution. The modification of treatment plan, i.e. how
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Figure 15: The locating accuracy of different detector angle coverage for both ar-
rangements.
Figure 16: The dose distribution and DVH for pancreas tumor case if setup error
exists without EGRT. The tumor is in red color; other colored organs are the organs
at risk.
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Figure 17: The dose distribution and DVH for pancreas tumor case if setup error
exists with EGRT. The tumor is in red color; other colored organs are the organs at
risk.
Figure 18: Fluence map modification. Upper: before modification; lower: after
modification. The numbers indicate the field angles.
the treatment plan is shifted, is shown in Figure 18.
3.8.2 Lung tumor case
As shown in Figure 13(c), with full detector coverage, the tumor can be seen from
reconstructed images. The comparison of the detected motion and the simulated
motion is shown in Figure 19.(a) , with the error of detection shown in Figure 19 (b).
The result indicates an average error of about 2 mm.
For 150 degree coverage, an averaged error of about 3 mm is observed. The
comparison of simulated motion and detected motion and error of detection is shown
in Figure 20.
The dose is delivered the similar way as gating technique, which means the dose is
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Figure 19: The locating accuracy of lung tumor case for full detector coverage.
Figure 20: The locating accuracy of lung tumor case for 150 degree coverage.
Figure 21: The dose distribution and DVH for lung tumor case if setup error exists
with EGRT based on gating delivering technique. The tumor is yellow color; other
colored organs are the organs at risk.
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delivered only in certain position such as base phase position. The dose distribution
is shown in Figure 21. It can be seen that with EGRT, the margin can be significantly
reduced while still maintaining a highly conformal dose distribution. For un-gated
dose delivery, which is simulated by delivering the dose equally among all the phases,





In tomotherapy scheme, the two key issues, tumor tracking and treatment plan modi-
fication still apply. That is, in the tomotherapy scheme, there are also two algorithmic
difficulties in the detailed implementation. The first is how to locate the 3D location
of the tumor in real time from the detected LORs. The second is how to deliver the
dose based on the acquired tumor location information and an existing treatment
plan. The scope of this simulation is to demonstrate the concept of EGRT and to
provide viable solutions to the two challenges above. Another purpose of this sim-
ulating case is to validate the EGRT concept in the tomotherapy scheme and get a
preliminary result.
However, since dose is delivered slice by slice in tomotherapy scheme, there are
some differences between tomotherapy scheme and IMRT scheme. In tomotherapy,
treatment is done for all angles and full sinogram is available because linac is rotating
fast. Also, the Linac responds to individual LOR and the dose is delivered to one
LOR rather than to one field. As mentioned in previous chapter, the main content in
this chapter will focus on how to validate the EGRT concept in tomotherapy scheme.
4.2 Proposed EGRT tomotherapy system design
As discussed before, EGRT system mainly consists of a typical Linac for radiation
delivery and PET detectors for tumor localization. They are mounted together in
the same gantry such that the EGRT system can do tumor tracking to get the tumor
position and simultaneously deliver the radiation precisely with the help of real-time
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tumor location. This is quite different from the PET-guided radiation therapy which
takes quite a long time to acquire PET images before the radiation delivery and
the tumor tracking is not being done concurrently with the treatment. A schematic
diagram of EGRT system for tomotherapy scheme is shown in Figure 22.
(a) LOR detection (b) Dose delivery
Figure 22: The schematic diagram of the proposed EGRT system for tomotherapy
scheme. Left: one coincidence event is detected; Right: The linac has been rotated
to align with this LOR within a very short time and simultaneously delivers the
radiation along this LOR.
In EGRT tomotherapy scheme, after the positron emitter injected into patient,
the gamma-ray detectors as used in a PET scanner detect the LORs generated by
positron events. Once the positron event is determined to be inside the tumor target
based on the uptake ratio and the treatment plan, the corresponding LOR will be
enqueued into a list of beamlets waiting for dose delivery. At the first time when the
rotating Linac meets the enqueued LOR, radiation will be delivered along the LOR
passing through the target.
4.3 Planning sinogram, emission sinogram and treatment
plan modification
It is very useful to apply the concept of sinogram in EGRT. Some examples of sino-
grams are shown in Figure 23. Planning sinogram is obtained by converting the
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planned dose data, which is obtained by optimization, from the 1D matrix into a 2D
matrix with a particular size. In this work, 3600 beam around the phantom has been
used to deliver the dose. 3600 beams are composed of 180 fields and each field has
20 lateral beams. Therefore, the planning sinogram will have a size of 180 by 20.
Thus, each grid of the sinogram corresponds to one unique beam position among all
the 3600 beams. The intensity of each grid is the planned dose for the corresponding
beam position.
Each LOR can be represented uniquely by a data pair of the angle of the line
and its displacement from origin. GATE outputs the position of two ending point
of LOR. This data output can be converted into the Emission sinogram, each grid
of which also signifies one beam position. Note that the displacements are converted
into the sequence number of the 20 beamlets. In this case, the size of the Emission
sinogram is intentionally made the same with the planning sinogram and thus the
grids of Emission sinogram coincide with those in planning sinogram in terms of
beam positions. The main difference is that the intensity of Emission sinogram is
the number of coincidence counts received in the beam positions indicated by grid
position. When performing treatment, we expect to deliver the planned dose in each
grid of planning sinogram according to the number of counts in the corresponding
grid of Emission sinogram.
Actually, Figure 23 also shows how we can get the location of the tumor and how
we should modify the treatment plan based on the tumor location information. As
shown, in emission sinogram, if there is no setup error, the sino-curve of the tumor will
be almost a straight line; however, if there is setup error, that is, the tumor shifts from
its original location, the sino-curve of the tumor will be a sinusoidal curve rather than
a straight line. From the phase and the amplitude of this curve, the tumor position
change can be determined. Then, the same shift amount of the emission sinogram
can be applied to planning sinogram. This is how we modify the treatment plan in
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Figure 23: Sinograms involved in simulations to demonstrate concept of treatment
without using margins. Emission sinogram will be shifted if error exists, then we can
modify the planning sinogram according to the shift amount of Emission sinogram.
tomotherapy scheme.
4.4 Adaptive dose delivery
Suppose we have obtained a complete sinogram set, including a Emission sinogram
and the corresponding planning sinogram. Imagine a particular grid, by looking up
Emission sinogram, we get the number of coincidence counts in this grid is P ; by
looking up planning sinogram, we know the intensity to be delivered for the position






By delivering dose equally among all the detected LORs, the error of dose delivery
will be minimized. We are able to deliver the planned dose completely if:
• we have enough counts during the treatment;
• we know the complete Emission sinogram before the treatment.
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Figure 24: Adaptive dose delivery of EGRT tomotherapy.
For the first condition, it will be achieved with a reasonably long treatment time; as for
the second one, it is impossible to be met because we are responding to each individual
LOR from the beginning to the end of treatment and thus we are doing treatment in
real time and therefore the Emission sinogram is formed dynamically. However, this
problem can be solved using our proposed adaptive dose delivery scheme.
Before treatment starts, we do a pre-treatment to obtain one initial Emission
sinogram to be updated from. Then we can continuously update the Emission sino-
gram with incoming new counts. We estimate the final Emission sinogram from the
updated Emission sinogram. Then we assign the dose for each count according to
the estimated Emission sinogram and compensate for previous errors simultaneously
before delivery since the estimated Emission sinogram is always noisy. With more
and more counts coming in, the estimated final Emission sinogram will be more and
more precise and the error will, ideally, converge to zero. When the number of treat-
ment counts is reached, the treatment is finished and the planned dose is delivered
completely. The optimized dose distribution and DVH will be achieved with negligi-
ble errors. The adaptive dose delivery workflow is shown in Figure 24. For how to
compensation for previous error, it is shown in Figure 25.
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Figure 25: Compensation method in adaptive dose delivery.
4.5 Treatment scheme in tomotherapy
Different therapy scheme may have different treatment scheme, although the concept
of EGRT is the same. For tomotherapy scheme, the treatment scheme is shown
in Figure 26. The treatment scheme of EGRT tomotherapy starts from injecting
radioactive tracers into GTV and the LORs data can be obtained to be input into
the adaptive dose delivery module to achieve a successful treatment. The core part
of EGRT tomotherapy is the adaptive dose delivery method and treatment plan
modification if tumor position change is detected.
4.6 Evaluation
4.6.1 Overview
The workflow is illustrated in Figure 27. Since the EGRT system typically contains
two main components, i.e. Linac and PET detector, the workflow has two sepa-
rate paths of simulation, which converge in the end to achieve successful treatment
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Figure 26: Treatment scheme of EGRT tomotherapy.
using proposed adaptive dose delivery algorithm. Starting from the same phantom
geometry, the left side path first calculates the dose kernel, which is the dose dis-
tribution achieved by beamlets with unit intensity, via VMC++, then computes the
planned dose for all simulated beamlets positions via optimization, finally rearranges
the planned dose data into planning sinogram; the right side path first simulates
the emission process using GATE package and output the coincidence counts data,
then convert the data into Emission sinogram. Using the two sinograms together,
we expect to deliver exactly the prescribed dose to the phantom via proposed adaptive
dose delivery scheme and achieve a desired dose distribution.
4.6.2 Geometry of evaluation phantom
The geometry of simulated prostate cancer phantom is shown in Figure 28(a). The
human body is simulated using an ellipse with a major and minor semi-axis of 18 and
12 cm respectively. PTV and organs at risk (OARs) are circles with a radius of 3
cm for PTV, 2.5 cm for rectum and 2 cm for other OARs (bladder, left femoral head
and right femoral head). Conventionally, for IMRT, the treatment planning is done
at five fixed angles. In our simulation, the treatment planning is done every other
degree over 360 degrees since this is a tomotheapy scheme. This means a total of
180 angle positions where source can be placed. At each source position, the width
of X-ray is specified using 20 beamlets, each of which has a size of 5mm by 5mm
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Figure 27: Method of Evaluation for EGRT Tomotherapy.
at the SAD. These 20 beamlets are arranged in one line with a total length of 10
cm and their common center is placed in the midpoint of source-to-origin line which
is perpendicular to beamlets line. Since the source is placed sufficiently far from
the phantom, the beams going through the beamlets can be approximately viewed as
parallel beams. The total coverage of X-ray for each source position is 10 cm, covering
the whole PTV region. Therefore, with 180 source positions and 20 beamlets for each
source position, we have 3600 possible different beams in total to deliver the dose for
each slice.
The geometry of treatment without using margins is shown in Figure 28(b). The
original PTV’s radius is 3 cm and we assume the margin is 1 cm which makes the
CTV’s radius 2 cm. Planned setup means CTV is at the phantom center. Treat-
ment setup means CTV is some distance, in our simulation set to be 1 cm which is
just the margin value, deviated from the planned setup.
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(a) Geometry of prostate cancer phantom
(b) Geometry for treatment without using mar-
gins
Figure 28: Geometry involved in simulations.
4.6.3 Optimization
The goal of optimization is to determine the planned dose intensity for all the 3600
possible beams so that the PTV and OARs will achieve the desired dose distribution
and dose volume histogram (DVH) if the planned dose for each beam position is
delivered. In our simulation, the prescribed dose for PTV is set to be 10−3 for the
consideration of convenience, while for other OARs it is set to be a sufficiently low
value. The optimization is done using MOSEK package. The main output of the
optimization is the planned dose intensity for all 3600 beams. A typical optimized
DVH is shown in Figure 30(c).
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4.6.4 Concept of treatment without margins
Previously, we are treating PTV rather than CTV. The PTV is composed of CTV plus
margins. The reason why we use safety margins (typically 1 to 2 cm in lung cancer)
is because of tumor motion or patient setup error. This leads to increased dose to
normal tissues surrounding CTV. In EGRT tomotherapy, since Emission sinogram
can tell the position of the tumor from the sinogram itself, margins are no longer
needed. The case of patient setup error is simulated. Emission sinogram will indicate
whether there is setup error in process of real-time therapy. As shown in Figure 23, if
there is setup error, Emission sinogram will look like (c) rather than (a). That is, the
Emission sinogram is shifted because of position change. However, planning sinogram
is based on the planned setup position and unaware of setup error. Thus it cannot
be directly applied for dose delivery. However, from Emission sinogram, we know the
position change of CTV so that we can modify the planning sinogram according to
that particular change.
As shown in Figure 28(b), if the CTV is at the planned setup position, which is
in the phantom center, the Emission sinogram is a straight line. If the CTV is set up
incorrectly, which means the CTV is shifted some distance from the phantom center,
the Emission sinogram is a sinusoidal curve, shifted from the straight line because of
the position change. We can perform the same amount of shift of the Emission sino-
gram on the planning sinogram to obtain the modified planning sinogram. Because
the CTV deviates not so far from its planned setup position, we can assume this mod-
ified planning sinogram approximated equals the optimized sinogram for the current
treatment setup. And this assumption is validated in our simulation by generating
dose distribution and the error turns out to be negligible.
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4.7 Results
This section show two important results about this study: dose distribution and
DVH. Dose distribution is shown in Figure 29 and DVH is shown in Figure 30. From
Figure 29, it can be seen that even the tumor shifts from its planned position, the
radiation is still able to locate it with the help of emission guidance and then achieve
a satisfied dose distribution. This can be further verified by DVH shown in Figure 30.
(a) DVH for treatment setup using unmodified
sinogram
(b) DVH for treatment using modified sinogram
Figure 29: Dose distribution of treatment without using margins. The number on iso-
dose line is the percentage of prescribed dose. Geometry is the same as Figure 28(b).
Left: dose distribution without any method if setup error exists, corresponding to
Figure 30(a). Right: dose distribution using proposed method even if setup error
exists, corresponding to Figure 30(b).
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(a) DVH for treatment setup using unmodified
sinogram
(b) DVH for treatment using modified sino-
gram
(c) optimized DVH for planned setup
Figure 30: DVHs of treatment without using margins.
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CHAPTER V
DISCUSSION, CONCLUSION AND FUTURE WORK
5.1 Discussion and conclusion
Our preliminary simulation results indicate that EGRT is able to deliver conformal
dose distribution to both shifted stationary tumor and fast moving tumor by tracking
the tumor position accurately. One of the biggest advantages of emission guidance
is that the margins for compensating uncertainties that are routinely used will be
significantly reduced or even completely eliminated. This is validated through our
simulations. However, treatment without margin is not the sole clinical benefit or
may not even the most important one of EGRT. EGRT is able to provide further
useful information that may affect the future development of the radiation therapy of
cancer. For example, EGRT is able to distinguish the active part of tumor and the
dead part, allowing the research of biological treatment planning.
In this work, EGRT can be further improved to exhibit more accurate and powerful
guidance by enhancing the proposed algorithms in several aspects. First, the current
reconstruction algorithm used is simple parallel beam reconstruction. All the oblique
LORs, about 90 percent of total LORs data, are wasted, degrading the temporal
resolution and increasing the data noise. Furthermore, the localization algorithm can
also be improved. One way is to optimize the interpolation parameters which have
an influence on the locating accuracy. Another way is to introduce weighting factors
into localization process, since currently every voxel of the tumor is weighted equally.
However, the inner tumor voxels has more influence to determine the tumor location
for current localization algorithm and therefore deserves higher weighting factors than
the outer tumor voxels. Also, current simulation assumes that the detector is not
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rotating at all to loosen the hardware constraints. However, this may not be the
case because the linac is rotating between different fields and PET detectors will
also be rotating. In that case, sinogram data can be made complete if an estimation
algorithm based on prior information is well established.
Although with the proved feasibility, there are some issues needed to be ad-
dressed. One of the main challenges comes from the dose caused by radioactive
tracers. Through our investigation, this nuclear medicine dose will not be a big is-
sue due to the fact that the dose caused by one-time injection of radioactive tracers
is actually significantly less than one-time cone beam CT (CBCT) imaging. Plus,
there are potentially several methods of reducing the nuclear medicine dose in de-
tailed EGRT implementation. For example, a 4D reconstruction rather than simple
parallel beam reconstruction should be implemented so that the data will be used
more efficiently, meaning that only smaller activity is needed or lower dose rate can
be used. Or shortening the time of therapy will further reduce the activity that is
needed. Another possible method will be to do a regional reconstruction so that not
only the locating accuracy will be improved but also the events needed to locate the
tumor will be reduced. Also, in current practice, due to increased margins, the desired
radiation dose must be delivered over a series of fractions (typically 30-40, over a 5
week period) in order to minimize toxicity to healthy surrounding tissue. This will
significantly increase CBCT dose, however, with EGRT, the fractions can be reduced
because of very small margins or even no margins.
Another issue of EGRT will be the uptake ratio of the radioactive tracers. Current
simulation indicates that the higher the uptake ratio, the easier and faster the tumor
will be located. This is understandable because with higher uptake ratio, the tumor
will be more easily distinguished from the background organs or tissues. Our simu-
lation results have already proved that as long as the background organs or tissues
are not physically mixed with each other, the uptake ratio issue will not disable the
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algorithm. For those the tumor is immersed with the background, ideally as long as
the uptake ratio is not exactly the same, the tumor should be able to be located.
From our simulation experience, in order to achieve an acceptable locating accuracy,
the tumor can be located with an uptake ratio about 2:1 to 10:1 for reducing setup
margins, 5:1 to 15:1 for reducing motion margins. For those tumors with uptake ratio
lower than 2:1, EGRT may not be suitable for them. However, most of the tumors
have an uptake ratio larger than 2:1, especially for lung tumor whose motion issue is
still not resolved in current radiation therapy practice. Although current work does
not include the cases in which tumor may deform, EGRT is able to resolve the tumor
deformation issue in the future work through some algorithm improvement.
In summary, this work has developed a set of basic algorithms to validate a new
emission guided radiation therapy concept, which uses positron emission for tumor
treatment guidance. This set of algorithms mainly solves the issues of tumor tracking
and maintaining treatment performance by modifying the treatment plan for EGRT.
High accuracy and high temporal resolution of tumor tracking can be achieved, re-
ducing the margins and providing the tumor position change for treatment plan mod-
ification. Treatment performance can thus be maintained by modifying the treatment
plan instantly and right before radiation delivery. Therefore, unlike the conventional
PET-guided radiation therapy system, EGRT system is able to perform real-time
tumor tracking and radiation therapy simultaneously, greatly improving the perfor-
mance of current radiation therapy.
5.2 Future work
A lot of work can be done in various aspects. First of all, the localization accuracy
needs to be further improved, as well as the stability of the accuracy. Temporal
resolution also needs to be further increased. Although current simulation have al-
ready shown acceptable results in both locating accuracy and temporal resolution,
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things may not turn out to be as perfect as those shown in simulations in practical
systems. Potential problems may show up in future phototype system and clinical
EGRT systems and its applications.
Moreover, tumor deformation may be a great challenge in future development of
EGRT applications. Tumor deformation can be incorporated by determining possible
deformation shapes which are to be used in tumor localization. Although it is ide-
ally practical to include tumor deformation into current algorithm theme, it is still
difficult to take that into account while still maintaining a sufficiently good result.
Therefore, some creative and persistent work is needed here. Also, the counterpart
on tomotherapy scheme is only finished partially. We have already shown that the
EGRT tomotherapy scheme is able to detect the setup error; however, we are still
working on the motion problem. Motion problem is more challenging for tomother-
apy scheme than IMRT scheme because the tracking of tumor position is not finished
until the dose is finished delivering.
The future work not only represents the challenges that lie in front of the develop-
ment of EGRT, but also at the same time indicates the bright future of EGRT since
once those issues are addressed, EGRT will have broad application in clinical practice
and bring more patient comfort and care.
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